Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis

被引：28

作者：

Caocci, Giovanni ^{[1
]}

Mulas, Olga ^{[2
]}

Annunziata, Mario ^{[3
]}

Luciano, Luigiana ^{[4
]}

Bonifacio, Massimiliano ^{[5
]}

Orlandi, Ester Maria ^{[6
]}

Pregno, Patrizia ^{[7
]}

Galimberti, Sara ^{[8
]}

Rossi, Antonella Russo ^{[9
]}

Abruzzese, Elisabetta ^{[10
]}

Iurlo, Alessandra ^{[11
]}

Martino, Bruno ^{[12
]}

Sgherza, Nicola ^{[13
]}

Binotto, Gianni ^{[14
]}

Castagnetti, Fausto ^{[15
]}

Gozzini, Antonella ^{[16
]}

Fozza, Claudio ^{[17
]}

Bocchia, Monica ^{[18
]}

Sicuranza, Anna ^{[18
]}

Stagno, Fabio ^{[19
]}

Efficace, Fabio ^{[20
]}

Usala, Emilio ^{[2
]}

De Gregorio, Fiorenza ^{[4
]}

Scaffidi, Luigi ^{[5
]}

Elena, Chiara ^{[6
]}

Pirillo, Francesca ^{[7
]}

Barate, Claudia ^{[8
]}

Trawinska, Malgorzata Monika ^{[10
]}

Cattaneo, Daniele ^{[11
]}

Labate, Claudia ^{[12
]}

Gugliotta, Gabriele ^{[15
]}

Molica, Matteo ^{[21
]}

Specchia, Giorgina ^{[9
]}

La Nasa, Giorgio ^{[1
]}

Foa, Robin ^{[21
]}

Breccia, Massimo ^{[21
]}

机构：

[1] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy

[2] Businco Hosp, Hematol & Transplant Ctr, Cagliari, Italy

[3] Cardarelli Hosp, Hematol Unit, Naples, Italy

[4] Federico II Univ Naples, Hematol Unit, Naples, Italy

[5] Univ Verona, Sect Hematol, Dept Med, Verona, Italy

[6] Fdn IRCCS Policlin S Matteo Univ Hosp, Hematol Unit, Pavia, Italy

[7] Azienda Osped Univ Citta Salute & Sci, Hematol Unit, Turin, Italy

[8] Univ Pisa, Sect Hematol, Dept Clin & Expt Med, Pisa, Italy

[9] Univ Bari, Hematol & Transplants Unit, Bari, Italy

[10] Tor Vergata Univ, St Eugenio Hosp, Hematol Unit, Rome, Italy

[11] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy

[12] Azienda Osped Bianchi Melacrino Morelli, Hematol Unit, Reggio Di Calabria, Italy

[13] Casa Sollievo Sofferenza Hosp, Hematol & Transplant Ctr, San Giovanni Rotondo, Italy

[14] Univ Padua, Hematol Unit, Padua, Italy

[15] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[16] Univ Florence, AOU Careggi, Hematol Unit, Florence, Italy

[17] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy

[18] Univ Siena, Azienda Osped Univ Senese, Hematol Unit, Siena, Italy

[19] Ferrarotto Hosp, Hematol Unit, Catania, Italy

[20] Italian Grp Adult Hematol Dis GIMEMA, Data Ctr & Hlth Outcomes Res Unit, Rome, Italy

[21] Sapienza Univ, Policlin Umberto 1, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 07期

关键词：

POPULATION;

D O I：

10.1002/ajh.25102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E159 / E161

页数：3

共 7 条

[1]

Aghel N, 2017, VASC HEALTH RISK MAN, V13, P293, DOI 10.2147/VHRM.S108874

[2] Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment [J].

Breccia, Massimo ;

Molica, Matteo ;

Zacheo, Irene ;

Serrao, Alessandra ;

Alimena, Giuliana .

ANNALS OF HEMATOLOGY, 2015, 94 (03) :393-397

[3] Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients [J].

Castagnetti, Fausto ;

Breccia, Massimo ;

Gugliotta, Gabriele ;

Martino, Bruno ;

D'Adda, Mariella ;

Stagno, Fabio ;

Carella, Angelo Michele ;

Avanzini, Paolo ;

Tiribelli, Mario ;

Trabacchi, Elena ;

Visani, Giuseppe ;

Gobbi, Marco ;

Salvucci, Marzia ;

Levato, Luciano ;

Binotto, Gianni ;

Capalbo, Silvana Franca ;

Bochicchio, Maria Teresa ;

Soverini, Simona ;

Cavo, Michele ;

Martinelli, Giovanni ;

Alimena, Giuliana ;

Pane, Fabrizio ;

Saglio, Giuseppe ;

Rosti, Gianantonio ;

Baccarani, Michele .

HAEMATOLOGICA, 2016, 101 (10) :1200-1207

[4] Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United States [J].

Coutinho, Anna D. ;

Makenbaeva, Dinara ;

Farrelly, Eileen ;

Landsman-Blumberg, Pamela B. ;

Lenihan, Daniel .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10) :676-683

[5] Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia A Population-Based Cohort Study [J].

Dahlen, Torsten ;

Edgren, Gustaf ;

Lambe, Mats ;

Hoglund, Martin ;

Bjorkholm, Magnus ;

Sandin, Fredrik ;

Sjalander, Anders ;

Richter, Johan ;

Olsson-Stromberg, Ulla ;

Ohm, Lotta ;

Back, Magnus ;

Stenke, Leif .

ANNALS OF INTERNAL MEDICINE, 2016, 165 (03) :161-+

[6] Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemia [J].

Latagliata, Roberto ;

Carmosino, Ida ;

Vozella, Federico ;

Volpicelli, Paola ;

De Angelis, Federico ;

Loglisci, Maria Giovanna ;

Salaroli, Adriano ;

De Luca, Maria Lucia ;

Montagna, Chiara ;

Serrao, Alessandra ;

Molica, Matteo ;

Diverio, Daniela ;

Nanni, Mauro ;

Mancini, Marco ;

Breccia, Massimo ;

Alimena, Giuliana .

HEMATOLOGICAL ONCOLOGY, 2017, 35 (02) :232-236

[7] Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios [J].

Saglio, Giuseppe ;

le Coutre, Philipp ;

Cortes, Jorge ;

Mayer, Jiri ;

Rowlings, Philip ;

Mahon, Francois-Xavier ;

Kroog, Glenn ;

Gooden, Kyna ;

Subar, Milayna ;

Shah, Neil P. .

ANNALS OF HEMATOLOGY, 2017, 96 (08) :1303-1313

← 1 →